Related content

Novel CSF biomarkers for Alzheimer’s disease and mild cognitive impairment

By Hu William   Chen-Plotkin Alice   Arnold Steven   Grossman Murray   Clark Christopher   Shaw Leslie   Pickering Eve   Kuhn Max   Chen Yu   McCluskey Leo   Elman Lauren   Karlawish Jason   Hurtig Howard   Siderowf Andrew   Lee Virginia   Soares Holly   Trojanowski John  

Acta Neuropathologica, Vol. 119, Iss. 6, 2010-06 ,pp. : 669-678

Springer Publishing Company

Access to resources Recommend Favorite

Platelet phospholipase A₂ activity in Alzheimer’s disease and mild cognitive impairment

By Gattaz W. F.   Forlenza O. V.   Talib L. L.   Barbosa N. R.   Bottino C. M. C.  

Journal of Neural Transmission, Vol. 111, Iss. 5, 2004-05 ,pp. : 591-601

Springer Publishing Company

Access to resources Recommend Favorite

Inverse association of cortisol serum levels with T-tau, P-tau 181 and P-tau 231 peptide levels and T-tau/Aβ 1-42 ratios in CSF in patients with mild Alzheimer's disease dementia

By Laske Christoph  

European Archives of Psychiatry and Clinical Neuroscience, Vol. 259, Iss. 2, 2009-02 ,pp. : 80-85

Springer Publishing Company

Access to resources Recommend Favorite

MILD COGNITIVE IMPAIRMENT: AGING TO ALZHEIMER’S DISEASE

By Snowden J. S.  

Brain, Vol. 127, Iss. 1, 2004-01 ,pp. : 231-233

Oxford University Press

Access to resources Recommend Favorite

Macrophage Colony-Stimulating Factor (M-CSF) in Plasma and CSF of Patients with Mild Cognitive Impairment and Alzheimer's Disease

By  

Current Alzheimer Research, Vol. 7, Iss. 5, 2010-08 ,pp. : 409-414

Bentham Science Publishers

Access to resources Recommend Favorite